Publications by authors named "Kemp Cease"

Claim this Profile
A
A Lyophilizable Nanoparticle Vaccine Specific for a Novel Linear Neutralizing Epitope in the α2-α3 Helices of Domain 3 of Lethal Factor from .
Jon Oscherwitz, Kemp Cease, David Milich, Thomas Braun, Fen Yu

Toxins (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Lyophilizable Nanoparticle Anthrax Vaccine Targeting the Loop-Neutralizing Determinant in Protective Antigen from .
Jon Oscherwitz, Kemp Cease, David Milich, Tod Merkel, Thomas Braun

Microorganisms· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
Radhika Raghunathan, Kemp Cease, Sandra Troeschel, Lili Zhao, Milton Gross

Am J Clin Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.
Feng-Ming Kong, Randall K Ten Haken, Matthew Schipper, Kirk A Frey, James Hayman, Kemp B Cease

JAMA Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non-Small-Cell Lung Cancer.
Angel Qin, Lindsay Street, Kemp Cease, Benjamin L Viglianti, Edus H Warren

Clin Lung Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.
Jon Oscherwitz, Kemp B Cease

PLoS One· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.
Jon Oscherwitz, Conrad P Quinn, Kemp B Cease

Vaccine· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.
Jon Oscherwitz, Daniel Feldman, Fen Yu, Kemp B Cease

Vaccine· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo mapping of a protective linear neutralizing epitope at the N-terminus of alpha hemolysin from Staphylococcus aureus.
Jon Oscherwitz, Raul Muñoz-Planillo, Fen Yu, Gabriel Núñez, Kemp B Cease

Mol Immunol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy.
Shuanghu Tiger Yuan, Richard K J Brown, Lujun Zhao, Randall K ten Haken, Milton Gross, Kemp B Cease

Radiat Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staphylococcus δ-toxin induces allergic skin disease by activating mast cells.
Yuumi Nakamura, Jon Oscherwitz, Kemp B Cease, Susana M Chan, Raul Muñoz-Planillo

Nature· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax.
Jon Oscherwitz, Fen Yu, Jana L Jacobs, Kemp B Cease

Clin Vaccine Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Carepartners: Improving patients' symptom management by engaging informal caregivers.
Maria J Silveira, Charles W Given, Kemp B Cease, Alla Sikorskii, Barbara Given

BMC Palliat Care· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
Jon Oscherwitz, Fen Yu, Kemp B Cease

J Immunol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD20 tandem-epitope immunogen elicits antibody in mice that binds murine cell surface CD20 and depletes splenic B cells in vivo.
Jon Oscherwitz, Thomas E Gribbin, Kemp B Cease

Mol Immunol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy.
Xu-Wei Cai, Lu-Ying Xu, Li Wang, James A Hayman, Andrew C Chang, Kemp B Cease

Int J Radiat Oncol Biol Phys· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen.
Jon Oscherwitz, Fen Yu, Kemp B Cease

Infect Immun· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.
Jon Oscherwitz, Fen Yu, Jana L Jacobs, Te-Hui Liu, Philip R Johnson, Kemp B Cease

Infect Immun· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to treatment in patients with stage III non-small cell lung cancer.
Li Wang, Candace R Correa, James A Hayman, Lujun Zhao, Kemp Cease

Int J Radiat Oncol Biol Phys· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.
Li Wang, Candace R Correa, Lujun Zhao, James Hayman, Gregory P Kalemkerian, Kemp Cease

Int J Radiat Oncol Biol Phys· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic vaccines for anthrax based on recombinant adeno-associated virus vectors.
Te-Hui Liu, Jon Oscherwitz, Bruce Schnepp, Jana Jacobs, Fen Yu, Kemp B Cease

Mol Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
Lujun Zhao, Kerby Sheldon, Ming Chen, Moli S Yin, James A Hayman, Kemp B Cease

Lung Cancer· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.
Lujun Zhao, Brady T West, James A Hayman, Susan Lyons, Kemp Cease

Int J Radiat Oncol Biol Phys· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.
Jon Oscherwitz, F C Hankenson, Fen Yu, Kemp B Cease

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis